Braxia Scientific CEO to Deliver Keynote Address at H.C. Wainwright & Co. 1st Annual Mental Health Conference: Neuropsychiatry, Psychedelics, and Beyond Post published:June 24, 2022 Post category:Press Release
Field Trip Health Ltd. to Present at the H.C. Wainwright 1st Annual Mental Healthcare Conference on June 27, 2022 Post published:June 23, 2022 Post category:Press Release
BetterLife To Participate at the H.C. Wainwright 1st Annual Mental Health Conference Post published:June 23, 2022 Post category:Press Release
Silo Pharma Expands License Agreement and Patent Portfolio Post published:June 23, 2022 Post category:Press Release
Numinus Applies for International Patent Filing of Psychedelics Production Process Post published:June 22, 2022 Post category:Press Release
HAVN Life To Be Featured On Viewpoint with Dennis Quaid Post published:June 22, 2022 Post category:Press Release
Algernon Pharmaceuticals Announces Issuance of Patent for Ifenprodil for the Treatment of Idiopathic Pulmonary Fibrosis Post published:June 22, 2022 Post category:Press Release
Mindset Pharma and Top Psychiatric Research Hospital, CAMH, Enter Innovative Collaboration to Build Molecular Profile of MSP-1014 Compared to Psilocybin Post published:June 22, 2022 Post category:Press Release
Small Pharma to Participate in the H.C. Wainwright 1st Annual Mental Health Conference on June 27, 2022 Post published:June 22, 2022 Post category:Press Release
Field Trip Health Ltd. Schedules Fiscal Fourth Quarter and Full Year 2022 Results Conference Call for Thursday, June 30, 2022 at 8:30 AM ET Post published:June 22, 2022 Post category:Press Release